Similarly, the reduction in NMNAT1 expression, by unbalancing NAD+ homeostasis, causes mitochondrial dysfunction, is associated with insulin resistance, and impairs hepatic insulin signaling and hepatokine expression [41]. The gene discussed is NMNAT1; the disease is Insulin resistance.